In this study, we assessed the effect of the SK1 selective inhibitor, PF-543 and a SK1/ceramide synthase inhibitor, RB-005 on pulmonary and cardiac remodelling in a mouse hypoxic model of PAH. This evidence concerns the gene TLCD3B and pulmonary arterial hypertension.